Summit Partners invests in ApoCell - MarketLine Financial Deals

Summit Partners invests in ApoCell

Summit Partners invests in ApoCell - MarketLine Financial Deals
Summit Partners invests in ApoCell
Published Sep 30, 2009
1 pages — Published Sep 30, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

ApoCell, Inc., a molecular diagnostics company, has raised private equity funding from Summit Partners.

  
Source:
Document ID
MA10066_091006
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Summit Partners invests in ApoCell" Sep 30, 2009. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Summit-Partners-invests-in-ApoCell-2052-9710>
  
APA:
MarketLine Financial Deals. (2009). Summit Partners invests in ApoCell Sep 30, 2009. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Summit-Partners-invests-in-ApoCell-2052-9710>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.